| Name | Title | Contact Details |
|---|---|---|
Scott Berger |
Vice President Product Development | Profile |
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".
ChromaScape is a specialty chemicals company based in Independence, Ohio, with a production facility in Stow. Founded in 1998, it has roots dating back to 1968. The company operates six manufacturing and distribution facilities across the U.S. and boasts over 100 years of combined expertise in colorant formulation and supply chain management. ChromaScape focuses on lean manufacturing, digital integration, and customer-centric processes to enhance quality and efficiency. ChromaScape offers a range of products, including colorants and additives for various industries. In landscaping, it provides Amerimulch® colored mulch and rubber/aggregate colorants. For packaging, it supplies Aquablak® aqueous carbon black dispersions and CEL Chemical adhesives for waterproof corrugated board. In construction, its Innotech® decorative concrete colorants and ChromaPave® asphalt sealcoat colorants are widely used. The company has expanded its portfolio through strategic acquisitions, enhancing its offerings in printing, packaging, and consumer specialties.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Pret is a winter sport helmet company based in Park City, Utah. We develop gear that reflects our demand for ultimate performance and innovation, our love of the outdoors & the people who share our passion.
4Liberty is a leading technical & professional services firm focused on energy & infrastructure. We manage large scale programs and projects for diverse clients across North America. We help utilities through the energy transition necessary to meet customer expectations, adhere to government mandates, and reach sustainable goals. We help commercial, government, and municipal customers implement the modern infrastructure needed to bolster security, improve connectivity, and ensure environmental and social justice.